The relative sensitivity of the Clinical Global Impressions Scale and the Brief Psychiatric Rating Scale in antipsychotic drug trials

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Stefan Leucht, R R Engel

Abstract

Although the Clinical Global Impression (CGI) and the Brief Psychiatric Rating Scale (BPRS) are both frequently used in drug trials for schizophrenia, their relative sensitivity in detecting differences between antipsychotics has not yet been examined. We therefore reanalyzed original patient data from all four pivotal, randomized controlled studies (n = 1205) that compared amisulpride with haloperidol in patients with schizophrenia. The sensitivity of the BPRS vs the CGI-improvement and the CGI-severity scales in detecting between-drug differences was estimated by calculating effect sizes and their 95% confidence intervals for both continuous (standardized mean differences) and dichotomous outcomes (odds ratios). The primary end points were the last observation carried forward results at study end points pooling all studies, but the results of the observed cases at different study weeks and the results of the single studies were also examined. The effect sizes derived from the BPRS and from the CGI were similar. When the single studies were pooled, all outcomes analyzed showed a statistically significant superiority of amisulpride compared to haloperidol as early as 2 weeks after initiation of treatment. The CGI may be as sens...Continue Reading

References

Jun 15, 2011·Journal of Child and Adolescent Psychopharmacology·Kelly BlankenshipChristopher J McDougle
Feb 1, 2008·Schizophrenia Bulletin·Stefan LeuchtJ M Kane
Dec 25, 2009·CNS Drugs·Gary RemingtonOfer Agid
Jul 14, 2010·Psychiatry Research·Abderrahmane BourredjemFrench "Stimulation dans le Trouble Obsessionnel Compulsif (STOC)" Study Group
May 4, 2016·Psychiatry Research·Mario MüllerStephan T Egger
Oct 1, 2015·Journal of Anxiety Disorders·David C HoughtonDouglas W Woods
Jan 13, 2009·Acta Psychiatrica Scandinavica. Supplementum·Stefan LeuchtJ M Kane
Jul 24, 2015·BJPsych Open·Ketan Dipak Jethwa, Oluwademilade A Onalaja
Sep 12, 2014·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Harpreet KaurRitushree Kukreti
May 3, 2015·The British Journal of Psychiatry : the Journal of Mental Science·Paul HuttonJoanna Moncrieff
Apr 29, 2014·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Myrto T SamaraStefan Leucht
Apr 15, 2014·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Gagan FervahaGary Remington
Jan 7, 2011·The International Journal of Neuropsychopharmacology·Stefan LeuchtJohn M Davis
Feb 10, 2017·International Clinical Psychopharmacology·Daniel SchuepbachSabine C Herpertz
Jun 9, 2017·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Ludger HargarterAndreas Schreiner
Jun 28, 2017·Behavioral Sciences·Boadie W DunlopMark H Rapaport
Feb 5, 2011·Journal of Psychopharmacology·Thomas R E Barnes, Schizophrenia Consensus Group of British Association for Psychopharmacology
Aug 15, 2013·The International Journal of Social Psychiatry·JianZhong YangSung-Chan Pauline
Apr 16, 2011·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Florian ZemanMichael Landgrebe
Mar 27, 2018·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Jonathan Green, Shruti Garg

Citations

Apr 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·S A Montgomery, M Asberg
Jul 1, 1992·Pharmacopsychiatry·M Beneke, W Rasmus
Aug 1, 1988·The Journal of Hospital Infection·J Cohen
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Mar 31, 1998·The British Journal of Psychiatry : the Journal of Mental Science·J C SpellerJ L Alberts
Jun 3, 2000·International Clinical Psychopharmacology·L ColonnaWerner Rein
Oct 14, 2000·European Psychiatry : the Journal of the Association of European Psychiatrists·P CarrièreT Lempérière
Jul 4, 2001·Psychopharmacology·K WahlbeckS Leucht
Feb 2, 2002·The American Journal of Psychiatry·Stefan LeuchtWerner Kissling
Dec 5, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Daniel SechterAmisulpride Study Group
Jun 11, 2003·Archives of General Psychiatry·John M DavisIra D Glick
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON
Dec 4, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·A John RushMartin B Keller

Related Concepts

Amisulpride
Antipsychotic Effect
Confidence Intervals
Assay OF Haloperidol
Schizophrenia
AS 2
Transcription Initiation
Severity of Illness Index
Haloperidol
Antipsychotic Agents

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

© 2020 Meta ULC. All rights reserved